Patrick G. Enright, Director at Jazz Pharmaceuticals plc (JAZZ), sold 2,178 shares at $152.33 ($332K) on 2022-08-08, disclosed to the SEC on 2022-08-09.
Seasonal sale ($332k) by Director — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.33 | 1,089 | $166K | 50.0% |
| 2 | $152.33 | 1,089 | $166K | 50.0% |
| Total | $152.33 avg | 2,178 | $332K | 100% |
| Filing → |
| ZBIO | BUY | 2025-10-14 | $2.5M | — | Filing → |
| VERA | BUY | 2025-06-25 | $10.6M | — | Filing → |
| BIOA | BUY | 2024-09-27 | $7.2M | — | Filing → |